Related Experiment Video

Updated: Apr 28, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.1K

Cellular immunotherapy strategies for Ewing sarcoma

Claudia Rossig1

  • 1University Children's Hospital Muenster, Pediatric Hematology & Oncology, Albert-Schweitzer Campus 1, Building A1, 48149 Muenster, Germany.

Immunotherapy
|June 5, 2014
PubMed

Insights

Immunotherapy for Ewing sarcoma involves T cells targeting intracellular or surface antigens and NK cells. Challenges include antigen heterogeneity and targeting normal cells, requiring effective cell homing and function in the tumor microenvironment.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Therapeutics

Background:

  • Ewing sarcoma is a rare bone and soft tissue cancer characterized by a specific chromosomal rearrangement.
  • Current preclinical research explores immunotherapy as a treatment strategy.

Purpose of the Study:

  • To review the preclinical development of immunological treatment strategies for Ewing sarcoma.
  • To identify major challenges and considerations for effective immune targeting of Ewing sarcoma.

Main Methods:

  • Expansion of T cells with native or grafted T-cell receptors targeting intracellular antigens.
  • T-cell engineering with chimeric antigen receptors (CARs) targeting surface antigens.
  • Evaluation of in vitro preactivated Natural Killer (NK) cells for anti-cancer activity.

Main Results:

  • Immunotherapy approaches include T-cell-based strategies and NK cell therapies.
  • Significant challenges exist, including antigen expression heterogeneity and off-target effects on normal cells.
  • Ensuring effective homing and function of therapeutic cells within the immunosuppressive tumor microenvironment is critical.

Conclusions:

  • Effective immune targeting of Ewing sarcoma requires overcoming antigen heterogeneity and ensuring therapeutic cell efficacy.
  • Future strategies must address tumor microenvironment challenges for successful immunotherapy.
Keywords:
Ewing sarcomaNK cellT-cell receptorT-cell therapychimeric antigen receptorregulatory T celltumor antigentumor immune escapetumor microenvironment

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

11.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K